GLF
SOPH icon

Groupe la Francaise’s SOPHiA GENETICS SOPH Stock Holding History

Groupe la Francaise’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-120
Closed -$569 – 738
2025
Q3 		$569 Buy
+120
New +$412 ﹤0.01% 750

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Groupe la Francaise's SOPH Position: Q4 2025 in Review

Groupe la Francaise sold out of SOPHiA GENETICS (SOPH) in Q4 2025, closing a stake of 120 shares — an estimated $569 sold.

Groupe la Francaise first reported a position in SOPH in Q3 2025 and held it in 1 quarter. The position peaked at $569 in Q3 2025. 42 funds tracked by Wall St. Rank hold SOPH as of Q4 2025.

  • Groupe la Francaise reported no remaining SOPHiA GENETICS position as of Q4 2025 after selling out during the quarter.
  • Groupe la Francaise sold 120 SOPHiA GENETICS shares in Q4 2025, an estimated $569.
  • Groupe la Francaise first reported a position in SOPHiA GENETICS in Q3 2025 and held it in 1 quarter.
  • Groupe la Francaise's SOPHiA GENETICS position peaked at $569 in Q3 2025.
  • 42 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.